This page is part of the PACIO Personal Functioning and Engagement Implementation Guide (v2.0.0-ballot: STU 2 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 1.0.0. For a full list of available versions, see the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: PFEIG-AllergyACE - JSON Representation

Raw json | Download

{
  "resourceType" : "AllergyIntolerance",
  "id" : "PFEIG-AllergyACE",
  "meta" : {
    "profile" : [
      🔗 "http://hl7.org/fhir/us/core/StructureDefinition/us-core-allergyintolerance"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AllergyIntolerance PFEIG-AllergyACE</b></p><a name=\"PFEIG-AllergyACE\"> </a><a name=\"hcPFEIG-AllergyACE\"> </a><a name=\"PFEIG-AllergyACE-en-US\"> </a><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}\">Active</span></p><p><b>verificationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification confirmed}\">Confirmed</span></p><p><b>category</b>: Medication</p><p><b>criticality</b>: High Risk</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 372733002}\">Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)</span></p><p><b>patient</b>: <a href=\"Patient-PFEIG-patientBSJ1.html\">Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)</a></p><p><b>asserter</b>: <a href=\"Patient-PFEIG-patientBSJ1.html\">Betsy Smith-Johnson Female, DoB Unknown ( http://example.org/identifiers/patient#10A3D58WH1600)</a></p><p><b>lastOccurrence</b>: 2011-10</p><h3>Reactions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Substance</b></td><td><b>Manifestation</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 308963}\">captopril 12.5 MG Oral Tablet</span></td><td><span title=\"Codes:{http://snomed.info/sct 427195008}\">Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)</span></td></tr></table></div>"
  },
  "clinicalStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
        "code" : "active"
      }
    ]
  },
  "verificationStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
        "code" : "confirmed"
      }
    ]
  },
  "category" : [
    "medication"
  ],
  "criticality" : "high",
  "code" : {
    "coding" : [
      {
        "system" : "http://snomed.info/sct",
        "code" : "372733002",
        "display" : "Substance with angiotensin-converting enzyme inhibitor mechanism of action (substance)"
      }
    ]
  },
  "patient" : {
    🔗 "reference" : "Patient/PFEIG-patientBSJ1"
  },
  "asserter" : {
    🔗 "reference" : "Patient/PFEIG-patientBSJ1"
  },
  "lastOccurrence" : "2011-10",
  "reaction" : [
    {
      "substance" : {
        "coding" : [
          {
            "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code" : "308963",
            "display" : "captopril 12.5 MG Oral Tablet"
          }
        ]
      },
      "manifestation" : [
        {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "427195008",
              "display" : "Hyperkalemia caused by angiotensin-converting enzyme inhibitor (disorder)"
            }
          ]
        }
      ]
    }
  ]
}